Company News in the Life Science Industry

»

Reset 

George Clinical Awarded Taiwanese Drug License

SYDNEY, May 15, 2019 /PRNewswire/ -- George Clinical, a global scientifically-backed clinical research organization (CRO), has significantly expanded its capabilities in Taiwan having been granted a license to import drugs into the country for clinical trials on behalf of sponsors. The development... Read more ››

By: PR Newswire Association LLC. - 15 May 2019
Related companies:  GEORGE CLINICAL PTY LTD

Canopy Rivers Backs BioLumic - Shines Light on New AgTech for the Medical Cannabis Industry

BioLumic's Proprietary Technology Harnesses the Power of UV Light to Sustainably Improve Crop Performance and Yield

Read more ››
By: PR Newswire Association LLC. - 15 May 2019

InMed Pharmaceuticals Reports Third Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update

VANCOUVER, May 15, 2019 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis platform technology for the manufacturing of pharmaceutical-grade cannabinoids as well as an R&D pipeline... Read more ››

By: PR Newswire Association LLC. - 15 May 2019
Related companies:  InMed Pharmaceuticals Inc.

Crescita Therapeutics Reports 2019 First Quarter Results

Year-over-Year Revenue Growth of 16.4%
Positive Adjusted EBITDA for Third Consecutive Quarter
And Generates $2.3 Million in Cash

Read more ››
By: PR Newswire Association LLC. - 15 May 2019
Related companies:  Crescita Therapeutics Inc.

Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders

LAVAL, QC, May 15, 2019 /CNW Telbec/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (Crescita or the Company), a commercial dermatology company with a portfolio of non-prescription skincare and prescription drug products for the treatment and care of skin conditions, diseases and their... Read more ››

By: PR Newswire Association LLC. - 15 May 2019
Related companies:  Crescita Therapeutics Inc.

Beleave Receives Unanimous Approval from Hamilton Planning Committee

TORONTO, May 15, 2019 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to provide an update on its meeting with the Hamilton Planning Committee on May 14, 2019.

Read more ››
By: PR Newswire Association LLC. - 15 May 2019
Related companies:  Beleave Inc.

Clarius Simplifies Ultrasound Telemedicine with Latest Release

VANCOUVER, British Columbia, May 15, 2019 /PRNewswire/ -- Clarius Mobile Health, a leader in portable handheld ultrasound, released a telemedicine solution called Clarius Live. The simple-to-use feature allows any Clarius user to easily request real-time assistance while performing an ultrasound... Read more ››

By: PR Newswire Association LLC. - 15 May 2019
Related companies:  Clarius Mobile Health Corp.

Diversicare Wins Customer and Employee Approved Awards From NRC Health

Read more ››
By: Nasdaq / GlobenewsWire - 15 May 2019

AXIM® Biotechnologies Announces Additional Purchase Order for Nutraceutical Product With Leading Direct Selling Company

Read more ››
By: Nasdaq / GlobenewsWire - 15 May 2019
Related companies:  AXIM Biotechnologies, Inc.

Tizona Elects Daniel K. Spiegelman to Its Board of Directors

Read more ››
By: Nasdaq / GlobenewsWire - 15 May 2019

Surface Oncology to Present at Two Upcoming Healthcare Conferences

Read more ››
By: Nasdaq / GlobenewsWire - 15 May 2019
Related companies:  Surface Oncology, Inc.

Ohr Pharmaceutical Reports Financial Results for the Fiscal Second Quarter of 2019

Read more ››
By: Nasdaq / GlobenewsWire - 15 May 2019
Related companies:  Ohr Pharmaceutical Inc.

Eton Pharmaceuticals to Present at 20th Annual B. Riley FBR Investor Conference

Read more ››
By: Nasdaq / GlobenewsWire - 15 May 2019
Related companies:  Eton Pharmaceuticals, Inc.

Agios Announces the Randomized Phase 3 ClarIDHy Trial of TIBSOVO® (ivosidenib) Achieved its Primary Endpoint in Previously Treated IDH1 Mutant Cholangiocarcinoma Patients

Read more ››
By: Nasdaq / GlobenewsWire - 15 May 2019
Related companies:  Agios Pharmaceuticals, Inc.

ChromaDex to Present at the 20th Annual B. Riley FBR Investor Conference

Read more ››
By: Nasdaq / GlobenewsWire - 15 May 2019
Related companies:  ChromaDex Inc.

Emergent BioSolutions Prepares for Initial Shipments of AV7909 Anthrax Vaccine Candidate into the Strategic National Stockpile

Read more ››
By: Nasdaq / GlobenewsWire - 15 May 2019
Related companies:  Emergent BioSolutions Inc.

Bellicum Pharmaceuticals to Present Updated Results for BPX-601 at the 2019 ASCO Annual Meeting

Read more ››
By: Nasdaq / GlobenewsWire - 15 May 2019
Related companies:  Bellicum Pharmaceuticals, Inc.

Agios to Present Clinical Data from its IDH Program at ASCO

Read more ››
By: Nasdaq / GlobenewsWire - 15 May 2019
Related companies:  Agios Pharmaceuticals, Inc.

Precision Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update

Read more ››
By: Nasdaq / GlobenewsWire - 15 May 2019
Related companies:  Precision Therapeutics Inc.

Spine Injury Solutions Announces Results for the Fiscal First Quarter Ended March 31, 2019

Read more ››
By: Nasdaq / GlobenewsWire - 15 May 2019
Related companies:  Spine Injury Solutions, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12 13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies